Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wright Medical Augments Ortho Extremities Biz With BioMimetic Purchase

This article was originally published in The Gray Sheet

Executive Summary

Firm expects to gain PMA approval in 2013 for BioMimetic’s Augment bone graft as a replacement for autologous bone graft in foot and ankle fusion procedures. Deal includes $190 million down, and up to $190 million more in milestone payments.

Advertisement

Related Content

Wright Sees Potential $1B+ Market Opportunity With Newly-Approved Orthobiologic
Wright Brings New Biologic To U.S. Ortho Space With Augment Approval
Vendor Inspections Hold Up Wright's Augment Graft Approval
FDA To Accept Wright’s PMA Amendment For Augment Bone Graft
FDA’s Augment Letter May Force Wright to Rewrite Turnaround Story
News Briefs: FDA Turns Down Wright’s Augment; Cook Resumes Zilver PTX Shipments; Luminex Restructures
Device/Diagnostics Quarterly Deal Statistics, Q4 2012
BioMimetic Amends Augment Bone Graft PMA, Expects Approval By 2014
FDA Panel Narrowly Supports BioMimetic's Augment Synthetic Bone Graft

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT031771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel